Express News | Lunai Bioworks (Nasdaq: Lnai) Signs Definitive Collaboration Agreement With Brainstorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement With BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrated roadmap spanning AI-driven patient stratification, human translational validation, biomarker
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
Amended Complaint Alleges 29.6 Million Failed to Deliver Shares and Single Day Trading Volume of 15.3 Times Shares Outstanding, Company Seeks Treble Damages Under Federal RICO StatuteWILMINGTON, Del.
9 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAmerican Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-market session. The market value of their outstanding shares is at $9.7 million. Greenland Mines (NASDAQ:
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersTenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-market session. The company's market cap stands at $4.0 million. Aditxt (NASDAQ:ADTX) shares rose 84.99% to $
Lunai Bioworks Pursues Legal Action Over Alleged Manipulation